Related Experiment Video
Updated: Jul 18, 2026
12:53
Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Progress towards development of a cholera subunit vaccine
Ronald K Taylor1, Thomas J Kirn, Niranjan Bose
1Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756, USA.
Chemistry & Biodiversity
|December 29, 2006
Summary
Developing a single-dose cholera subunit vaccine using Vibrio cholerae antigens like LPS and TCP offers advantages over current multi-dose oral vaccines, especially for young children. This approach aims for broader protection against epidemic cholera.
Area of Science:
- Infectious Diseases
- Vaccinology
- Microbiology
Background:
- Cholera remains a global health threat, with increasing incidence due to climate change and conflict.
- Current oral cholera vaccines require multiple doses and show variable efficacy, particularly in young children.
- An effective single-dose parenteral cholera vaccine is needed to improve global control efforts.
Purpose of the Study:
- To review current cholera vaccines and compare whole-cell vaccines with potential subunit vaccines.
- To explore Vibrio cholerae antigens, specifically LPS and TCP, as candidates for a novel subunit vaccine.
- To discuss the advantages and targeted applications of a new cholera subunit vaccine.
Main Methods:
- Review of existing literature on cholera vaccines and pathogenesis.
- Analysis of Vibrio cholerae antigens (LPS and TCP) and their immunogenic properties.
- Comparison of subunit vaccine strategies with current whole-cell vaccines.
Main Results:
- LPS and TCP antigens induce protective antibodies in animal models.
- Anti-LPS antibodies are associated with clinical protection in humans.
- Subunit vaccines offer potential for single-dose immunization and improved efficacy in specific populations.
Conclusions:
- A subunit cholera vaccine targeting LPS and TCP could overcome limitations of current vaccines.
- Single-dose parenteral immunization may provide broader and more reliable protection.
- Further development of subunit cholera vaccines is warranted to combat global epidemics.
Related Concept Videos
01:25Cholera
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...